Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Results of the MARS study in renal cell carcinoma

Dr Vincent Launay-Vacher - Pitie-Salpetriere Hospital, Paris, France
Results of the MARS study in renal cell carcinoma ( Dr Vincent Launay-Vacher - Pitie-Salpetriere Hospital, Paris, France )
31 Jan 2014

Dissecting the biology of the androgen receptor pathway

Dr Peter Nelson - Fred Hutchinson Cancer Research Center, Seattle, USA
Dissecting the biology of the androgen receptor pathway ( Dr Peter Nelson - Fred Hutchinson Cancer Research Center, Seattle, USA )
30 Jan 2014

Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)

Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland
Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC) ( Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland )
10 Jan 2014

Understanding the biology of the disease to guide treatment choices

Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Ireland
Understanding the biology of the disease to guide treatment choices ( Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Ireland )
10 Jan 2014

Predictors of response to mCRPC therapy: where do we stand?

Dr Ronald de Wit - Rotterdam Cancer Institute, Daniel den Hoed Cancer Center, Netherlands
Predictors of response to mCRPC therapy: where do we stand? ( Dr Ronald de Wit - Rotterdam Cancer Institute, Daniel den Hoed Cancer Center, Netherlands )
10 Jan 2014

Translational studies of CDK and PARP inhibitors

Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA
Translational studies of CDK and PARP inhibitors ( Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA )
19 Dec 2013

Preventing metastases by tackling exosomes

Dr Jeff Wrana - University of Toronto, Canada
Preventing metastases by tackling exosomes ( Dr Jeff Wrana - University of Toronto, Canada )
19 Dec 2013

Moving breast cancer stem cell therapies to the clinic

Dr Max Wicha - University of Michigan, Ann Arbor, USA
Moving breast cancer stem cell therapies to the clinic ( Dr Max Wicha - University of Michigan, Ann Arbor, USA )
19 Dec 2013

PIK3CA mutation predicts resistance to anti-HER2 treatment and chemotherapy

Dr Sibylle Loibl - German Breast Cancer Group
PIK3CA mutation predicts resistance to anti-HER2 treatment and chemotherapy ( Dr Sibylle Loibl - German Breast Cancer Group )
19 Dec 2013

Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy

Prof Adrian Harris - University of Oxford, Oxford, UK
Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy ( Prof Adrian Harris - University of Oxford, Oxford, UK )
19 Dec 2013

Careers in translational research

Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA
Careers in translational research ( Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA )
19 Dec 2013

New line of therapy for acute myeloid leukaemia

Dr David Taussig - Barts Cancer Institute, London, UK
New line of therapy for acute myeloid leukaemia ( Dr David  Taussig - Barts Cancer Institute, London, UK )
18 Dec 2013